CLINICAL_TRIALS
trial_result
· 2009-05-22
Clinical Trial Update: Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis [Phase 3]
Summary
A Phase 3 study evaluating darbepoetin alfa in subjects with chronic kidney disease receiving dialysis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Kidney Disease, Chronic Kidney Disease | Phase 3 | Status: COMPLETED